Search
for

    Learn

    2 / 2 results

      learn GT20029

      research compound made to degrade androgen receptors in scalp

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

    Research

    5 / 6 results

    Community Join

    5 / 263 results

      community Pyrilutamide phase III clinical trial results released

      in Research/Science  31 upvotes 1 year ago
      Pyrilutamide did not show effectiveness in regrowing hair compared to a placebo, but it may still help maintain existing hair by preventing DHT from causing follicle miniaturization. Some users believe it could be beneficial when used with other treatments like minoxidil, finasteride, and dutasteride.

      community Anyone excited for CosmeRNA coming this month?

      in Product  171 upvotes 2 years ago
      CosmeRNA, a new hair loss treatment, is expected to release soon and may become part of the "big three" treatments alongside finasteride and minoxidil. It works differently from finasteride by targeting androgen receptors in hair follicles, potentially offering fewer side effects.

      community GT20029 and PP405 the new fin and min that we been waiting for ?

      in Chat  36 upvotes 3 weeks ago
      PP405 and GT20029 are new hair loss treatments with different mechanisms from traditional options like Minoxidil and Finasteride. PP405 targets hair follicle stem cells to reactivate growth, while GT20029 works as an androgen receptor deleter, both requiring ongoing use for effectiveness.

      community A concern regarding the upcoming androgen degrader drug GT20029

      in Chat  11 upvotes 5 months ago
      GT20029 is a topical treatment that degrades androgen receptors to prevent hair thinning and loss, potentially offering fewer side effects than systemic treatments like finasteride. Concerns include its impact on hair texture and potential systemic effects, with market availability speculated in 3 to 5 years.